Clinical trials
Phase 3 Cystic Fibrosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 9 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 45 |
| PTC Therapeutics | 4 |
| Gilead Sciences | 2 |
| Insmed Incorporated | 2 |
| Amgen | 1 |
| Anthera Pharmaceuticals | 1 |
| Boehringer Ingelheim | 1 |
| Forest Laboratories | 1 |
| Imperial College London | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cystic Fibrosis | 61 |
| Exocrine Pancreatic Insufficiency | 2 |
| Fibrosis | 2 |
| Genetic Diseases, Inborn | 2 |
| Infant, Newborn, Diseases | 2 |
| Lung Diseases | 2 |
| Pancreatic Diseases | 2 |
| Pathologic Processes | 2 |
| Pseudomonas Infections | 2 |
| Respiratory Tract Diseases | 2 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.